These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2166540)

  • 21. [Effect of Coxsackie A13 and B3 virus infections on the primary immune response to sheep erythrocytes].
    Shestenko OP; Bocharov EF
    Vopr Virusol; 1988; 33(2):235-9. PubMed ID: 2842965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice.
    Kishimoto C; Hiraoka Y; Takada H
    Basic Res Cardiol; 2001 Sep; 96(5):439-45. PubMed ID: 11605990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics of enterovirus infection in cultures of human and mouse hybrid cells].
    Mustafina AN; Lashkevich VA; Koroleva GA
    Vopr Virusol; 1984; 29(4):476-80. PubMed ID: 6093387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxsackie virus infection in association with heart affection in man.
    Petrovicová A; Cervenka J; Egnerová A
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):251-7. PubMed ID: 2824602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells.
    Ménard R; Prévost MC; Gounon P; Sansonetti P; Dehio C
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1254-8. PubMed ID: 8577750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coxsackie B viral infection in the etiology and clinical pathogenesis of psoriasis].
    Korzhova TP; Shyrobokov VP; Koliadenko VH; Korniushenko OM; Akhramieieva NV; Stepanenko VI
    Lik Sprava; 2001; (3):54-8. PubMed ID: 11560028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is infection with group A streptococcus the only reason for rheumatic fever?--a case report of rheumatic fever coexisting with Coxsackie B1 virus infection].
    Górska A; Urban M; Głowińska B; Kowalewski M
    Przegl Lek; 1998; 55(7-8):418-9. PubMed ID: 10021888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of bacterial virulence factors and cytokines during in vitro macrophage infection by enteroinvasive Escherichia coli and Shigella flexneri: a comparative study.
    Bando SY; Moreno AC; Albuquerque JA; Amhaz JM; Moreira-Filho CA; Martinez MB
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):786-91. PubMed ID: 20944993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of Coxsackie B1 virus in Balb/C mice.
    Bocharov EV; Shalaurova OV
    Acta Virol; 1984 Jul; 28(4):345. PubMed ID: 6148863
    [No Abstract]   [Full Text] [Related]  

  • 30. [Meningomyocarditis caused by Coxsackie virus B4 in perinatology. Value of anti-Coxsackie virus B IgM].
    Haddad J; Keller F; Simeoni U; Gut JP; Messer J; Willard D
    Arch Fr Pediatr; 1988 Apr; 45(4):259-61. PubMed ID: 2841914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on virulence of Shigella flexneri.
    Witkowska D; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):603-10. PubMed ID: 373685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term persistence of coxsackieviruses in familial foci of infectious myocarditis patients].
    Lozovskaia LS; Zherdeva AN; Kogut EP; Shuvalova IA
    Vopr Virusol; 1986; 31(1):110-5. PubMed ID: 3008438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microinjected Coxsackie B1 virus does not replicate in HEp-2 cells.
    Modalsli KR; Bukholm G; Mikalsen SO; Degré M
    Virology; 1991 Dec; 185(2):888-90. PubMed ID: 1660207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterotypic reactions in a radioimmunoassay for coxsackie B virus specific IgM.
    Pugh SF
    J Clin Pathol; 1984 Apr; 37(4):433-9. PubMed ID: 6323548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coxsackie B infection in a general medical unit.
    Bell EJ; Irvine KG; Gardiner AJ; Rodger JC
    Scott Med J; 1983 Apr; 28(2):157-9. PubMed ID: 6306762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coxsackie B virus epidemiology and neonatal infection in Belgium.
    Druyts-Voets E; Van Renterghem L; Gerniers S
    J Infect; 1993 Nov; 27(3):311-6. PubMed ID: 8308326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructural evidence of immunological reactions during experimental coxsackievirus B-3 infection in the hibernating squirrel.
    Grodums EI; Dempster G
    Can J Microbiol; 1971 Mar; 17(3):359-63. PubMed ID: 4927920
    [No Abstract]   [Full Text] [Related]  

  • 38. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release.
    van Kuppeveld FJ; Hoenderop JG; Smeets RL; Willems PH; Dijkman HB; Galama JM; Melchers WJ
    EMBO J; 1997 Jun; 16(12):3519-32. PubMed ID: 9218794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Macrophage disappearance reaction in mice during an infection caused by Coxsackie B3 virus].
    Shestenko OP; Bocharov EF
    Vopr Virusol; 1989; 34(3):338-42. PubMed ID: 2552686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4.
    Goffard A; Alidjinou EK; Sané F; Choteau L; Bouquillon C; Caloone D; Lobert PE; Hober D
    Microbes Infect; 2013 Jan; 15(1):18-27. PubMed ID: 23108316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.